Phase 1 Graft Function Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Ischemia Reperfusion InjuryDelayed Graft Function

Rhode Island Hospital20 enrolled1 locationNCT04005469

Recruiting

Phase 1Phase 2

The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients

Kidney TransplantationDelayed Graft Function

First Affiliated Hospital of Chongqing Medical University47 enrolled2 locationsNCT07275632

Recruiting

Phase 1

The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation

Poor Graft Function

Institute of Hematology & Blood Diseases Hospital, China15 enrolled1 locationNCT06792682